NALCN
Sodium leak channel NALCN
Also known as: bA430M15.1, CanIon, NALCN_HUMAN, VGCNL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZF0
- Gene
- NALCN
- Ensembl
- ENSG00000102452
- Chromosome
- 13
- Canonical length
- 1738 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoli,Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Cytosol
OverviewNCBI Gene
This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
1738 residues, UniProt reviewed canonical sequence.
>Q8IZF0|NALCN
1 MLKRKQSSRV EAQPVTDFGP DESLSDNADI LWINKPWVHS LLRICAIISV ISVCMNTPMT
61 FEHYPPLQYV TFTLDTLLMF LYTAEMIAKM HIRGIVKGDS SYVKDRWCVF DGFMVFCLWV
121 SLVLQVFEIA DIVDQMSPWG MLRIPRPLIM IRAFRIYFRF ELPRTRITNI LKRSGEQIWS
181 VSIFLLFFLL LYGILGVQMF GTFTYHCVVN DTKPGNVTWN SLAIPDTHCS PELEEGYQCP
241 PGFKCMDLED LGLSRQELGY SGFNEIGTSI FTVYEAASQE GWVFLMYRAI DSFPRWRSYF
301 YFITLIFFLA WLVKNVFIAV IIETFAEIRV QFQQMWGSRS STTSTATTQM FHEDAAGGWQ
361 LVAVDVNKPQ GRAPACLQKM MRSSVFHMFI LSMVTVDVIV AASNYYKGEN FRRQYDEFYL
421 AEVAFTVLFD LEALLKIWCL GFTGYISSSL HKFELLLVIG TTLHVYPDLY HSQFTYFQVL
481 RVVRLIKISP ALEDFVYKIF GPGKKLGSLV VFTASLLIVM SAISLQMFCF VEELDRFTTF
541 PRAFMSMFQI LTQEGWVDVM DQTLNAVGHM WAPVVAIYFI LYHLFATLIL LSLFVAVILD
601 NLELDEDLKK LKQLKQSEAN ADTKEKLPLR LRIFEKFPNR PQMVKISKLP SDFTVPKIRE
661 SFMKQFIDRQ QQDTCCLLRS LPTTSSSSCD HSKRSAIEDN KYIDQKLRKS VFSIRARNLL
721 EKETAVTKIL RACTRQRMLS GSFEGQPAKE RSILSVQHHI RQERRSLRHG SNSQRISRGK
781 SLETLTQDHS NTVRYRNAQR EDSEIKMIQE KKEQAEMKRK VQEEELRENH PYFDKPLFIV
841 GREHRFRNFC RVVVRARFNA SKTDPVTGAV KNTKYHQLYD LLGLVTYLDW VMIIVTICSC
901 ISMMFESPFR RVMHAPTLQI AEYVFVIFMS IELNLKIMAD GLFFTPTAVI RDFGGVMDIF
961 IYLVSLIFLC WMPQNVPAES GAQLLMVLRC LRPLRIFKLV PQMRKVVREL FSGFKEIFLV
1021 SILLLTLMLV FASFGVQLFA GKLAKCNDPN IIRREDCNGI FRINVSVSKN LNLKLRPGEK
1081 KPGFWVPRVW ANPRNFNFDN VGNAMLALFE VLSLKGWVEV RDVIIHRVGP IHGIYIHVFV
1141 FLGCMIGLTL FVGVVIANFN ENKGTALLTV DQRRWEDLKS RLKIAQPLHL PPRPDNDGFR
1201 AKMYDITQHP FFKRTIALLV LAQSVLLSVK WDVEDPVTVP LATMSVVFTF IFVLEVTMKI
1261 IAMSPAGFWQ SRRNRYDLLV TSLGVVWVVL HFALLNAYTY MMGACVIVFR FFSICGKHVT
1321 LKMLLLTVVV SMYKSFFIIV GMFLLLLCYA FAGVVLFGTV KYGENINRHA NFSSAGKAIT
1381 VLFRIVTGED WNKIMHDCMV QPPFCTPDEF TYWATDCGNY AGALMYFCSF YVIIAYIMLN
1441 LLVAIIVENF SLFYSTEEDQ LLSYNDLRHF QIIWNMVDDK REGVIPTFRV KFLLRLLRGR
1501 LEVDLDKDKL LFKHMCYEME RLHNGGDVTF HDVLSMLSYR SVDIRKSLQL EELLAREQLE
1561 YTIEEEVAKQ TIRMWLKKCL KRIRAKQQQS CSIIHSLRES QQQELSRFLN PPSIETTQPS
1621 EDTNANSQDN SMQPETSSQQ QLLSPTLSDR GGSRQDAADA GKPQRKFGQW RLPSAPKPIS
1681 HSVSSVNLRF GGRTTMKSVV CKMNPMTDAA SCGSEVKKWW TRQLTVESDE SGDDLLDILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NALCN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 24
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 15 nTPM
- spinal cord: 11 nTPM
- cerebellum: 9.3 nTPM
- hypothalamus: 9.1 nTPM
- hippocampal formation: 8.8 nTPM
- basal ganglia: 8.4 nTPM
Single-cell type
- oligodendrocytes: 606 nCPM
- somatotrophs: 460 nCPM
- thyrotrophs: 454 nCPM
- lactotrophs: 454 nCPM
- oligodendrocyte progenitor cells: 440 nCPM
- gonadotrophs: 419 nCPM
Immune cell
- basophil: 2.5 nTPM
- neutrophil: 0.5 nTPM
- gdT-cell: 0.3 nTPM
- naive B-cell: 0.3 nTPM
- eosinophil: 0.2 nTPM
- memory B-cell: 0.2 nTPM
Brain region
- white matter: 54 nTPM
- cerebral cortex: 54 nTPM
- hypothalamus: 50 nTPM
- basal ganglia: 49 nTPM
- hippocampal formation: 47 nTPM
- medulla oblongata: 46 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NALCN.
Disease | AllUniProt
Conditions NALCN is implicated in, by any mechanism.
- Hypotonia, infantile, with psychomotor retardation and characteristic facies 1 (IHPRF1) MIM:615419
- Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) MIM:616266
Disease | GeneticClinVar
180 pathogenic / likely-pathogenic of 1,367 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital contractures of the limbs and face, hypotonia, and developmental delay
- Hypotonia, infantile, with psychomotor retardation and characteristic facies 1
- Inborn genetic diseases
- NALCN-related disorder
- Fetal akinesia deformation sequence 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 4.96
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transmembrane transport
- monoatomic ion transmembrane transport
- positive regulation of synaptic transmission, cholinergic
- positive regulation of synaptic transmission, GABAergic
- potassium ion transmembrane transport
- regulation of resting membrane potential
- sodium ion transmembrane transport
Molecular functions
- leak channel activity
- monoatomic cation channel activity
- sodium channel activity
- voltage-gated sodium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ion transport domain
- Voltage-dependent channel domain superfamily
- Ion transport protein
- Sodium leak channel NALCN
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NALCN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NALCN as an antibody target. Whether an autoantibody or antibody against NALCN could matter depends on whether native NALCN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NALCN is annotated at the cell surface, where native NALCN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NALCN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...